×
Cencora Cash on Hand 2010-2024 | COR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cencora cash on hand for the quarter ending June 30, 2024 was
$3.306B
, a
137.97% increase
year-over-year.
Cencora cash on hand for 2023 was
$2.592B
, a
23.5% decline
from 2022.
Cencora cash on hand for 2022 was
$3.388B
, a
33.02% increase
from 2021.
Cencora cash on hand for 2021 was
$2.547B
, a
44.6% decline
from 2020.
View More
Cencora Cash on Hand 2010-2024 | COR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cencora cash on hand for 2023 was
$2.592B
, a
23.5% decline
from 2022.
Cencora cash on hand for 2022 was
$3.388B
, a
33.02% increase
from 2021.
Cencora cash on hand for 2021 was
$2.547B
, a
44.6% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$125.1B
ICON (ICLR)
$25B
DiDi Global (DIDIY)
$19B
Avantor (AVTR)
$18.4B
Natera (NTRA)
$15.7B
Revvity (RVTY)
$15.4B
Viatris (VTRS)
$14.2B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.2B
Charles River Laboratories (CRL)
$10.6B
Sonic Healthcare (SKHHY)
$8.8B
Doximity (DOCS)
$7.4B
Bausch + Lomb (BLCO)
$7B
HealthEquity (HQY)
$6.8B
PACS (PACS)
$6.2B
Organon (OGN)
$5.1B
Life Times (LTH)
$4.9B
Sotera Health (SHC)
$4.7B
Surgery Partners (SGRY)
$4.1B
Concentras Parent (CON)
$3B
GoodRx Holdings (GDRX)
$2.8B
BrightSpring Health Services (BTSG)
$2.5B
Ardent Health Partners (ARDT)
$2.4B
Progyny (PGNY)
$2.2B
Alignment Healthcare (ALHC)
$2.2B
Premier (PINC)
$2.1B
Ryman Healthcare (RYHTY)
$1.9B
AMN Healthcare Services Inc (AMN)
$1.8B
Agilon Health (AGL)
$1.6B